TheAnswerPage

JULY 17, 2022

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Their findings included the following: “The average daily dose ranged between 1 and 50 mg/kg, with treatment length from 3 to 12 months (mean 6.2 12 September 2018.

Epilepsy

MMJ Recs

MARCH 10, 2022

Getting a Pennsylvania medical marijuana card 2022 is a straightforward process. The process of applying for your Pennsylvania MMJ card in 2022 is easy to navigate and can be done entirely online. Read on as we outline the steps involved and discuss how you can use your PA MMJ card in 2022!

Dispensary

Cannabis Law Report

AUGUST 31, 2021

Alixen™ 30 will target indications such as anxiety, insomnia, Parkinson’s Disease, and depression, while Alixen™ 100 will be used in the treatment of epilepsy.

Chronic Pain

The Cannigma

JUNE 25, 2022

Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. Up until 2022, no cannabis was grown in Poland so all products had to be imported, which led to massive delays in patients being able to access medication. Is CBD legal in Poland?

Legalization

MMJ Recs

JANUARY 25, 2022

So now that medical marijuana is finally available in Ohio, how do you get an Ohio MMJ card in 2022? Not all doctors in Ohio are certified to recommend medical marijuana treatment. How Do I Get My Ohio MMJ Card In 2022? What Are The Qualifying Conditions For A Medical Card In Ohio In 2022? Read on to find out!

Dispensary

MMJ Recs

MARCH 15, 2022

If you’ve decided that this is the year that you’d like to try MMJ treatment, read on for our guide on how to get your Missouri MMJ card in 2022 – and all the benefits it can bring you. Image by CBD-Infos-com on Pixabay : How do I get my Missouri MMJ card in 2022? The post How Do I Get My Missouri MMJ Card In 2022?

Conditions

Leaf Science

JULY 12, 2019

As legalization continues to be passed worldwide we hope (and will continue to educate) to see cannabis federally legal in the US and in most countries by 2022. As the debate over legalizing marijuana heats up, many continue to dispute the value of marijuana as a treatment for various ailments.

Indica

TheAnswerPage

JUNE 12, 2022

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A Review of the Safety and Effectiveness of Select Ingredients in Compounded Topical Pain Creams.” ” National Academies of Sciences, Engineering, and Medicine.

Epilepsy

Cannabis Law Report

SEPTEMBER 29, 2022

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. 27 September 2022. It is also alleged that the unlawful advertising included unapproved references to the treatment of serious diseases or conditions, including in some cases cancer and epilepsy.

Epilepsy

TheAnswerPage

AUGUST 26, 2022

This question begins “The Answer of the Day” series on the treatment effects of cannabinoids…. In August 2022, a systematic review and analysis of the use medical cannabinoids for the treatment of various medical indications was published. BMC Med 20, 259 (2022). Confidence Interval (CI) ? Spanagel, R.

Cannabinoids

TheAnswerPage

MAY 9, 2022

Currently, CBD-containing gels are being evaluated for the treatment of several pediatric disorders, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. See the Answer.

Epilepsy

TheAnswerPage

AUGUST 8, 2022

Currently, CBD-containing gels are being evaluated for the treatment of several pediatric disorders, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. See the Answer.

Epilepsy

TheAnswerPage

MAY 25, 2022

The results of recent clinical trials indicate that Cannabidiol (CBD) reduces seizures among patients with refractory epilepsies of various etiologies. A May 2021 study demonstrated that CBD does not lose its efficacy in controlling seizures over a treatment period of up to 60 months. Skirvin, Christina Wade. 29 May 2021 [link].

Clinical Trials

TheAnswerPage

JUNE 29, 2022

Yes, GW Pharmaceuticals (the makers of Epidiolex) had trialed CBDV in adult epilepsy, but the study did not meet its primary endpoint of seizure reduction. That trial did not continue.

Clinical Trials

TheAnswerPage

JANUARY 9, 2022

Yes, GW Pharmaceuticals (the makers of Epidiolex) had trialed CBDV in adult epilepsy, but the study did not meet its primary endpoint of seizure reduction. That trial did not continue.

Clinical Trials

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology.

Epilepsy

TheAnswerPage

JULY 18, 2022

In 2017, researchers performed an analysis of observational studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products and reported on the side effects of the CBD products: “The reports of mild (158/216, 76% vs. 148/447, 33%, p. Pamplona F, da Silva L and Coan A.

Epilepsy

TheAnswerPage

JUNE 21, 2022

There is a high strength of evidence for the efficacy of cannabinoid-based medicines for the treatment of intractable epilepsy, multiple sclerosis and cancer-related nausea. Which of these 3 conditions has the greatest relative number of patients using cannabinoid -based medicines to treat the condition? Schlag, A.K., O’Sullivan, S.E,

Epilepsy

TheAnswerPage

DECEMBER 31, 2021

There is a high strength of evidence for the efficacy of cannabinoid-based medicines for the treatment of intractable epilepsy, multiple sclerosis and cancer-related nausea. Which of these 3 conditions has the greatest relative number of patients using cannabinoid -based medicines to treat the condition? Schlag, A.K., O’Sullivan, S.E,

Epilepsy

TheAnswerPage

MAY 16, 2022

According to a presentation at the 2014 annual meeting of the American Epilepsy Society, an increasing dose of CBD was associated with significant increases in serum levels of topiramate, rufinamide, and N-desmethylclobazam. Presented at the annual meeting of the American Epilepsy Society, Seattle, December 5–9, 2014; abstract.

Epilepsy

TheAnswerPage

JUNE 27, 2022

What is the most effective combination of THC to CBD in the treatment of cancer pain? of epilepsy? Some registered trials are currently examining the efficacy of 3:1 THC:CBD, (ClinicalTrials.gov Identifier: NCT04042545) in cancer pain and 1:20 THC:CBD (ClinicalTrials.gov Identifier:NCT03024827) in epilepsy. Schlag, A.K.,

Epilepsy

TheAnswerPage

JANUARY 6, 2022

What is the most effective combination of THC to CBD in the treatment of cancer pain? of epilepsy? Some registered trials are currently examining the efficacy of 3:1 THC:CBD, (ClinicalTrials.gov Identifier: NCT04042545) in cancer pain and 1:20 THC:CBD (ClinicalTrials.gov Identifier:NCT03024827) in epilepsy. Schlag, A.K.,

Epilepsy

MMJ Recs

DECEMBER 15, 2021

This means that MMJ patients from other states will be able to purchase recreational marijuana in New York from late 2022. In order to get a New York medical marijuana card, a person must be a resident of New York State or be temporarily residing in the state for the purpose of receiving treatment. web portal.

Chronic Pain

Otherside Farms

MAY 12, 2022

Full spectrum distillate is being used to treat anything from muscular pains and anxiety to arthritis, epilepsy, and PTSD. Full-spectrum products have also been used for stress alleviation and pain treatment. They can also get high by eating a cookie or having a drink if they don’t feel like smoking.

Extraction

Cannabis Law Report

FEBRUARY 19, 2022

The AMCC anticipates that applicants may submit licenses to grow and/or manufacture medical cannabis on September 1, 2022. Under current law , the Florida Department of Health (FDOH) is responsible for overseeing the medical cannabis program, including issuing licenses to medical cannabis treatment centers. South Carolina.

Legalization

TheAnswerPage

MAY 20, 2022

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? Regulatory approval has been obtained in numerous countries outside the United States for the treatment of multiple sclerosis symptoms (nerve pain, spasticity, overactive bladder, and other symptoms).

Nerve Pain

TheAnswerPage

MAY 10, 2022

The FDA has approved a CBD product (Epidiolex) for the treatment of 3 rare forms of epilepsy. What is the mechanism of action of CBD in this anti-epileptic medication? How does CBD exert its anti-convulsant effects?

Epilepsy

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical

Cannabis Law Report

JANUARY 24, 2022

DUBLIN–(BUSINESS WIRE)–The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. from 2022 to 2028.

Legalization

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. From July 1, 2022, MMJ patients will not need to get a Board Registration card from the Virginia Board of Pharmacy in order to go to a dispensary and buy MMJ products. Recently, Virginia legalization has changed in several ways.

Patients

Freedom Leaf

OCTOBER 15, 2018

On the basis of their review, the agency approved Epidiolex for use in treating rare forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome). billion by 2022. billion by 2022. A month later, on May 16, the Department of Health and Human Services approved the FDA’s Epidiolex recommendation. will top $1.9

DEA

Veriheal

MARCH 23, 2023

The report states that the revision is an essential move for ensuring the legal use of cannabis-derived epilepsy drug Epidiolex , which is currently being reviewed as part of a series of clinical trials in Japan. Data suggests that the market has inflated from JPY4 billion (USD$3 billion) in 2019 to JPY17 billion (USD$13 billion) in 2022.

Legalization

Cannabis Law Report

JUNE 1, 2022

2 June 2022. These amounts represent frequently consumed dosages: up to 150mg/day over the counter; and up to 1500mg/day for conditions such as epilepsy, pain, sleep disorders and anxiety. They completed the task between 45-75 minutes after taking their assigned treatment, and then again at between 3.5

CBD

MMJ Recs

OCTOBER 10, 2021

Large numbers of OK residents are benefitting from medical marijuana treatment, and MMJ is also bringing massive economic benefits to the Sooner State. Oklahoma MMJ Is A Very Effective Treatment For Many Medical Conditions. MMJ doctors in OK are able to prescribe MMJ for any conditions that they believe will benefit from MMJ treatment.

Dispensary

Cannabis Law Report

MARCH 6, 2020

” In 2018, Europe was responsible for 23.2% of the world’s pharmaceutical sales with the size of the market in the EU-5 ( United Kingdom , Germany , Spain , France , and Italy ) set to grow by 25% between 2017 and 2022. This is the sixth patent grant that Kannalife has received. About KLS-13019.

Research and Development

MMJ Recs

FEBRUARY 9, 2022

So that more people can gain access to the treatment, the Louisiana MMJ program continues to expand, with more qualifying conditions added to the list as well as more cannabis included under the MMJ umbrella. Up until recently, medical marijuana could not be smoked in Louisiana, but that law changed on January 1 st , 2022.

Marijuana

MMJ Recs

AUGUST 29, 2022

As of August 2022, 213 medical marijuana dispensary licenses had been granted in Missouri, and out of these, 197 are operational and open for business. MMJ treatment has proved very popular with Missourians and there has turned out to be a huge demand for medical marijuana products in the Show Me State. Crohn’s disease. Hepatitis C.

Dispensary